Abstract
Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Current Drug Targets
Title:Pro-Oxidant Natural Products as Anticancer Agents
Volume: 13 Issue: 8
Author(s): Carmen Martin-Cordero, Antonio Jose Leon-Gonzalez, Jose Manuel Calderon-Montano, Estefania Burgos-Moron and Miguel Lopez-Lazaro
Affiliation:
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Abstract: Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Export Options
About this article
Cite this article as:
Martin-Cordero Carmen, Jose Leon-Gonzalez Antonio, Manuel Calderon-Montano Jose, Burgos-Moron Estefania and Lopez-Lazaro Miguel, Pro-Oxidant Natural Products as Anticancer Agents, Current Drug Targets 2012; 13 (8) . https://dx.doi.org/10.2174/138945012802009044
DOI https://dx.doi.org/10.2174/138945012802009044 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Anti-Infective Drug Discovery Biological Active Ingredients of Traditional Chinese Herb Astragalus membranaceus on Treatment of Diabetes: A Systematic Review
Mini-Reviews in Medicinal Chemistry γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Prostacyclin Synthase Gene: Genetic Polymorphisms and Prevention of Some Cardiovascular Diseases
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Potential Anti-inflammatory Effects of Hesperidin from the Genus Citrus
Current Medicinal Chemistry Prediction of Citrullination Sites on the Basis of mRMR Method and SNN
Combinatorial Chemistry & High Throughput Screening Porphyrin-Photosensitized Processes: Their Applications in the Prevention of Arterial Restenosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Combination of Phytochemicals as Adjuvants for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery The Prevalence and Progression of Arterial Calcification in Patients with End-Stage Renal Disease
Vascular Disease Prevention (Discontinued) Aluminum Induced Immunoexcitotoxicity in Neurodevelopmental and Neurodegenerative Disorders
Current Inorganic Chemistry (Discontinued) Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies
Current Aging Science Mass Spectrometry for Studying the Interaction between Small Molecules and Proteins
Current Proteomics Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Periodontal Film: A Potential Treatment Strategy for Periodontitis
Drug Delivery Letters A Novel Functional Macrophage Differentiated from Monocytes by Co- Stimulation with IL-12 and IL-18
Current Immunology Reviews (Discontinued) TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population
CNS & Neurological Disorders - Drug Targets A Developmental Approach to Drug-induced Liver Injury in Newborns and Children
Current Medicinal Chemistry Emerging Peptide Therapeutics for Inflammatory Autoimmune Diseases
Current Pharmaceutical Design Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies
Current Cancer Drug Targets Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science